arrow
D

Duk L. Na

Sungkyunkwan University School of Medicine
H指数:65
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Topography and risk factors of amyloid-related imaging abnormality: real-world data from 168 aducanumab-treated patients at a private clinic in South Korea

淀粉样蛋白相关影像异常的拓扑结构和风险因素:来自韩国一家私立诊所168例接受阿杜单抗治疗患者的真实世界数据

2026-10-210
OA
Plasma eMTBR-tau243 and p-tau205 as T2 biomarkers for biological staging and prognosis in Alzheimer’s disease

血浆eMTBR-tau243和p-tau205作为阿尔茨海默病生物分期和预后的T2生物标志物

2026-10-190
OAAI
A centiloid-scaled crossover of amyloid and tau influences on plasma p-Tau217 along the Alzheimer’s disease continuum

阿尔茨海默病连续谱中,以百分之一洛德为单位计的淀粉样蛋白和tau蛋白影响对血浆p-Tau217的交叉影响

2026-09-290
OAAI
Biomarker-integrated prognostic stagings for Alzheimer’s Disease

阿尔茨海默病的生物标志物综合预后分期

2026-02-020
OAAI
Double cutoff strategies for plasma pTau217 to predict Tau PET positivity across multiple assay platforms: Tau-enriched and Tau-scarce cohorts for cost-effective clinical use

血浆pTau217的双重截止策略,以预测跨多个测定平台的Tau PET阳性: Tau富集和Tau稀缺的队列,以实现具有成本效益的临床使用

2026-01-140
OAAI
CT-derived brain volumes and plasma p-Tau217 for risk stratification of amyloid positivity in early-stage Alzheimer’s disease

CT衍生的脑容积和血浆p-Tau217用于早期阿尔茨海默病中淀粉样蛋白阳性的风险分层

2025-10-300
OAAI
Age-related amyloid beta dynamics modeled with the generalized additive model for location, scale, and shape (GAMLSS) across diverse populations: Cross-sectional trajectories and longitudinal validation

基于位置-尺度-形状广义加性模型(GAMLSS)对多人群年龄相关淀粉样蛋白β动力学进行建模:横断面轨迹与纵向验证

2025-09-100
OAAI
Potential utility of plasma pTau217 for assessing amyloid and tau biomarker profiles

血浆pTau217在评估淀粉样蛋白和tau生物标志物谱中的潜在用途

2025-08-060
OAAI
Differential roles of Alzheimer's disease plasma biomarkers in stepwise biomarker-guided diagnostics

阿尔茨海默病血浆生物标志物在分步生物标志物指导诊断中的差异化作用

2025-02-050
OAAI